drugset

drugset / Trial / NCT06788444

Efficacy of Esketamine for Patients With Irritable Bowel Syndrome

NCT06788444 ↗

Recruiting 552 enrolled Beijing Tiantan Hospital

RandomizedParallel-groupSingle-blindTreatment

Summary

To explore the efficacy of a single low dose of esketamine for patients with irritable bowel syndrome (IBS).

Timeline

Start: 2025-09-18
Primary completion: 2026-12-31
Completion: 2027-12-31

Publications

Sun Z, Jiang L, Xing Y, Luo F. Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial. BMJ Open. 2025 Jun 23;15(6):e099793. doi: 10.1136/bmjopen-2025-099793.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esketamine	Other / unclassified	0.2 mg/kg	—

Indications